Kevin Wasserstein , MBA

Managing Partner
Versant Ventures
Menlo Park, CA

Kevin Wasserstein specializes in investing and building medical device companies at Versant. His work with entrepreneurs spans the earliest seed or concept stage of development through the entire life cycle of the company.

Kevin has more than eighteen years of venture capital and operating experience in medical device and high technology companies, and currently serves, or has served, in board or advisory roles with companies which include: Acclarent (acquired: Johnson & Johnson), Autonomic Technologies, Cardiac Concepts, LipoSonix (acquired: Medicis), Lutonix, Microfabrica, NeoGuide Systems (acquired: Intuitive Surgical), Rox Medical, Second Sight Medical, St. Francis Medical (acquired: Kyphon) and The Innovation Factory. In addition, he serves as a member of AdvaMed's National Venture Capital Advisory Board, and MDMA's Venture Capital Advisory Group.

Before joining Versant in 2002, Kevin held a variety of marketing and business development roles at Guidant Corporation. Most recently he served as head of marketing in Guidant's Cardiac Surgery Group, where he led the group's product/market development and launch initiatives. In Guidant's Peripheral and Carotid Group, Kevin developed and launched several first-generation stent and embolic protection devices while leading the carotid stent program's marketing activities. Previously, in Guidant's Compass Business Development Group, Kevin's responsibilities included acquisition, licensing and investment with both private and public medical device companies, and corporate strategy. His operational experience also includes business development at Heartstream, and engineering design and engineering management at Hughes Aircraft Company.

Kevin holds both Bachelor's and Master's degrees in Mechanical Engineering, specializing in product design, as well as an MBA, all from Stanford University.